AmerisourceBergen, a healthcare solutions company, recently launched a dedicated enterprise venture capital fund with $150 million allocated to investing in early to mid-stage healthcare-related startups.
The fund, AB Health Ventures, will invest in and partner with emerging healthcare startups around the world that are working to transform healthcare for people and animals. The fund will prioritize investments in entrepreneurs who are pursuing bold ideas in areas such as the future of pharmacy and distribution, clinical development and commercialization of pharmaceutical products, practical solutions for healthcare providers health and animal health.
The investment will help startups with things like prototyping solutions, testing with pilots, and accelerating scale through commercialization.
“I believe innovation is the catalyst for lasting progress and change, which is why AmerisourceBergen is committed to taking bold, innovative steps to achieve our goal and drive long-term growth,” said said Steve Collis, president and CEO of AmerisourceBergen. “The creation of AB Health Ventures will build on our track record of success as we identify meaningful partnerships that will bring emerging healthcare solutions to market and create a healthier future for all.”
AB Health Ventures is a wholly owned subsidiary of AmerisourceBergen. Touchdown Ventures, a firm specializing in corporate venture capital, will help manage the AB Health Ventures fund.